Aggregate risk score based on markers of hepatic steatosis, systemic inflammation, and renal stress to predict MACE across the CKM spectrum
The stage-specific evolution of risk drivers in Cardiovascular-Kidney-Metabolic (CKM) syndrome remains underexplored. This study evaluated the comparative and cumulative prognostic value of Fatty Liver Index (FLI), Cystatin C (CysC), and high-sensitivity C-reactive protein (hsCRP) for Major Adverse Cardiovascular...